Table 2.
Abnormality | Cancer type | Reference |
---|---|---|
Per gene mutation | breast, colorectal | 62 |
Deregulation of Per gene expression | breast, colorectal, endometrial, lung, CLL, DLBL, AML, CML | 28, 29, 59-61, 86-89 |
Single nucleotide polymorphisms in circadian genes associated with cancer risk and patient survival | breast, prostate, NHL | 30, 31, 65-67 |
Per1 translocation | CML | 90 |
Abbreviations: CLL, Chronic lymphocytic leukemia; DLBCL, Diffuse large B-cell lymphoma; AML, acute myeloid leukemia; CML, chronic myeloid leukemia; NHL, non-Hodgkin’s lymphoma.